Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-14

FDA Approved: RASAGILINE MESYLATE — Supplemental Application (Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Rasagiline Mesylate filed by Avet Pharmaceuticals, approving a generic version of the Parkinson's disease medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rasagiline mesylate (RASAGILINE MESYLATE)

Snippet

SUPPL AP for RASAGILINE MESYLATE (RASAGILINE MESYLATE)